Total Payments
$98,698
2024 Payments
$20,657
Companies
11
Transactions
73
Medicare Patients
20,131
Medicare Billing
$9.3M
Payment Breakdown by Category
Consulting$68,760 (69.7%)
Other$17,136 (17.4%)
Travel$11,331 (11.5%)
Food & Beverage$1,471 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $68,760 | 22 | 69.7% |
| Travel and Lodging | $11,331 | 13 | 11.5% |
| Acquisitions | $9,978 | 1 | 10.1% |
| Current or prospective ownership or investment interest | $7,158 | 6 | 7.3% |
| Food and Beverage | $1,471 | 24 | 1.5% |
| Unspecified | $0 | 7 | 0.0% |
Payments by Type
General
$98,698
66 transactions
Ownership
$0
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $61,419 | 34 | $0 (2024) |
| Alcon Research LLC | $19,626 | 13 | $0 (2024) |
| US Retina LLC | $17,136 | 14 | $0 (2023) |
| Genentech USA, Inc. | $159.02 | 4 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $149.53 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $93.01 | 2 | $0 (2024) |
| Coherus Biosciences Inc. | $26.52 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $25.31 | 1 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $22.15 | 1 | $0 (2023) |
| Alcon Laboratories Inc | $21.26 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,657 | 15 | Alcon Research LLC ($16,826) |
| 2023 | $11,461 | 6 | US Retina LLC ($9,978) |
| 2022 | $3,154 | 10 | US Retina LLC ($2,788) |
| 2021 | $24,066 | 8 | Alcon Vision LLC ($21,700) |
| 2020 | $3,686 | 4 | Alcon Vision LLC ($2,800) |
| 2019 | $34,238 | 25 | Alcon Vision LLC ($31,652) |
| 2018 | $1,421 | 3 | Alcon Research Ltd ($1,400) |
| 2017 | $14.69 | 2 | Genentech USA, Inc. ($14.69) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 11/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $149.53 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $11,160.00 | General |
| 10/24/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 10/24/2024 | Alcon Research LLC | — | Travel and Lodging | Cash or cash equivalent | $950.00 | General |
| 10/24/2024 | Alcon Research LLC | — | Travel and Lodging | Cash or cash equivalent | $31.93 | General |
| 10/18/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $113.00 | General |
| 10/09/2024 | Alcon Research LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: Ophthalmology | ||||||
| 10/08/2024 | Alcon Research LLC | — | Travel and Lodging | In-kind items and services | $643.10 | General |
| 10/08/2024 | Alcon Research LLC | — | Travel and Lodging | In-kind items and services | $311.93 | General |
| 10/08/2024 | Alcon Research LLC | — | Travel and Lodging | In-kind items and services | $297.00 | General |
| 10/08/2024 | Alcon Research LLC | — | Travel and Lodging | In-kind items and services | $250.00 | General |
| 10/08/2024 | Alcon Research LLC | — | Travel and Lodging | In-kind items and services | $172.39 | General |
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $68.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/04/2024 | Alcon Vision LLC | Constellation (Device) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: Ophthalmology | ||||||
| 12/18/2023 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Ophthalmology | ||||||
| 10/07/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Ophthalmology | ||||||
| 08/10/2023 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Ophthalmology | ||||||
| 06/13/2023 | US Retina LLC | — | Acquisitions | Cash or cash equivalent | $9,978.00 | General |
| 04/15/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| 2023 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 11/05/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RETINA | ||||||
| 10/01/2022 | Alcon Vision LLC | NGENUITY (Device), Constellation | Food and Beverage | In-kind items and services | $150.15 | General |
| Category: Ophthalmology | ||||||
| 10/01/2022 | Alcon Vision LLC | NGENUITY (Device), Constellation | Travel and Lodging | In-kind items and services | $17.15 | General |
| Category: Ophthalmology | ||||||
| 09/03/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $41.29 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 5,177 | 46,653 | $3.9M | $2.7M |
| 2022 | 19 | 5,168 | 20,706 | $3.4M | $2.3M |
| 2021 | 21 | 5,525 | 15,014 | $3.3M | $2.5M |
| 2020 | 18 | 4,261 | 11,947 | $2.6M | $1.9M |
Total Patients
20,131
Total Services
94,320
Medicare Billing
$9.3M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 99 | 34,680 | $1.4M | $997,220 | 73.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 161 | 1,454 | $1.4M | $964,509 | 69.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,465 | 1,845 | $225,253 | $148,633 | 66.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 305 | 1,644 | $309,730 | $130,870 | 42.3% |
| 92134 | Imaging of retina | Office | 2023 | 1,484 | 3,903 | $152,251 | $108,376 | 71.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 38 | 561 | $134,640 | $101,619 | 75.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 642 | 1,170 | $101,266 | $72,950 | 72.0% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 17 | 270 | $75,042 | $57,987 | 77.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 214 | 214 | $30,706 | $21,779 | 70.9% |
| J3590 | Unclassified biologics | Office | 2023 | 47 | 137 | $23,216 | $17,605 | 75.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 17 | 17 | $18,416 | $14,351 | 77.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 115 | $14,142 | $9,724 | 68.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $11,346 | $7,526 | 66.3% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 14 | 21 | $6,667 | $5,293 | 79.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 170 | 191 | $4,548 | $3,334 | 73.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 54 | 81 | $3,917 | $2,498 | 63.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 27 | 27 | $3,407 | $2,424 | 71.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 179 | 179 | $2,749 | $1,969 | 71.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 27 | $1,433 | $1,093 | 76.3% |
| 92250 | Photography of the retina | Office | 2023 | 34 | 35 | $1,398 | $861.25 | 61.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 11 | 12 | $1,031 | $608.20 | 59.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 160 | 1,496 | $1.4M | $1.0M | 73.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 88 | 2,056 | $704,108 | $455,949 | 64.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 53 | 7,560 | $292,950 | $225,600 | 77.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,424 | 1,817 | $222,156 | $138,670 | 62.4% |
About Dr. Kourous Rezaei, MD
Dr. Kourous Rezaei, MD is a Ophthalmology healthcare provider based in Harvey, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366428070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kourous Rezaei, MD has received a total of $98,698 in payments from pharmaceutical and medical device companies, with $20,657 received in 2024. These payments were reported across 73 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($68,760).
As a Medicare-enrolled provider, Rezaei has provided services to 20,131 Medicare beneficiaries, totaling 94,320 services with total Medicare billing of $9.3M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Retina Specialist
- Location Harvey, IL
- Active Since 12/15/2005
- Last Updated 02/04/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1366428070
Products in Payments
- Constellation (Device) $38,695
- NGENUITY (Device) $21,900
- Luxor (Device) $1,400
- VYZULTA (Drug) $149.53
- EYLEA HD (Biological) $68.76
- Lucentis (Biological) $33.75
- Cimerli (Biological) $26.52
- EYLEA (Biological) $24.25
- OZURDEX (Drug) $19.82
- VABYSMO (Drug) $12.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Harvey
Mathew Maccumber, Md, MD
Ophthalmology — Payments: $248,259
Ophthalmology $248,259
David Orth, Md, MD
Ophthalmology — Payments: $70,789
Ophthalmology $70,789
Timothy Flood, Md, MD
Ophthalmology — Payments: $57,253
Ophthalmology $57,253
Dr. Vivek Chaturvedi, M.d, M.D
Ophthalmology — Payments: $48,512
Ophthalmology $48,512
Serge Debustros, Md, MD
Ophthalmology — Payments: $34,365
Ophthalmology $34,365
Sohail Hasan, Md, MD
Ophthalmology — Payments: $30,975
Ophthalmology $30,975